盤中觀察 | CRO概念強勢,生物醫藥B類股普漲,美團績後漲超7%
uSMART盈立智投5月31日消息,週一港股,恆指高開低走,截至11:26,恆指跌0.43%,友邦保險跌4.12%,對恆指拖累最大;美團-W漲超7%,領漲恆指。
恆生科技指數衝高回落,截至11:29,漲0.72%,平安好醫生、京東集團、比亞迪電子、衆安在線漲超2%,小米、網易、百度漲超1%。
生物醫藥B類股走強,諾誠健華-B漲超10%,康方生物-B漲超8%,和鉑醫藥-B漲近8%,康希諾生物-B漲超6%,再鼎醫藥-SB漲超5%。
CRO(醫藥外包概念)繼續強勢,金斯瑞生物科技漲超8%,泰格醫藥、藥明生物、維亞生物漲超4%,藥明康德、康龍化成漲超2%。
美團-W漲超7%,致力於解決監管機構的反壟斷關切,第一季營收超過分析師預估。
海吉亞醫療盤中漲超11%,股價再創新高,成功收購廣西賀州廣濟醫院,收購事項獲多家大行唱好。
上海電氣H股跌超18%,此前發佈重大風險提示,子公司應收賬款普遍逾期,最壞情況或損失83億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.